Bay-Richter C, Linderholm KR, Lim CK, Samuelsson M, Trskman-Bendz L, Guillemin GJ, et al
The general framework most providers follow: For patients who are still actively losing weight, a consultation is still worthwhile your provider can assess your current changes, identify what to start now vs
Generalmente, se obtienen con receta mdica en farmacias autorizadas y centros de salud especializados
Post-Treatment : You may experience a slight increase in energy and overall well-being
Weight Reduction Observations A 2025 network meta-analysis published in the Journal of the Endocrine Society compared data from separate clinical trials: A systematic review examining multiple agents reported: Tirzepatide (15 mg): Up to 17.8% weight reduction from baseline Retatrutide (12 mg): Up to 24.2% weight reduction from baseline Semaglutide (2.4 mg): Up to 14% weight reduction for reference Phase 2 Trial Results: Retatrutide Published in the New England Journal of Medicine, the Phase 2 trial of retatrutide in adults with obesity showed dose-dependent reductions in body weight of up to 24% after 48 weeks of treatment